Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A major AI outage disrupted Claude, a popular chatbot used by crypto traders. This guide explains the outage, its pot...
A contrarian call on badly fallen stocks can pay off when the narrative shifts. This deep dive examines could beyond ...
As markets swing in early 2026, performing defensive stocks have provided steadier returns, drawing cash into staples...
Thor Industries reports a dramatic EPS surprise for Q2, with revenue rising modestly. Yet cash flow weakness and unev...
When AI generated war videos appear without disclosure, monetization can vanish. This piece explains what Xs warning ...
Target stock continues disappoint as the retailer unveils a growth plan amid slowing sales and mounting questions on ...
Broadcom is set to report Q1 FY2026 after the close as investors weigh AI-driven demand and margins. This live earnin...
In March 2026, traders are weighing the top platforms for E-Mini futures as volatility returns and liquidity remains ...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...
Elon Musk's X Money beta rollout ignites XRP price prediction chatter as traders weigh the chances of crypto integrat...
Markets are betting that rates will edge lower this year, nudging investors toward income-focused and rate-sensitive ...